Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

5.10
-0.1600-3.04%
Post-market: 5.07-0.0300-0.59%19:50 EDT
Volume:1.06M
Turnover:5.40M
Market Cap:229.49M
PE:-2.35
High:5.33
Open:5.26
Low:5.03
Close:5.26
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:0.98
T/O Rate:6.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:0.86
PE(LYR):-2.71

Loading ...

Small U.S. Stocks Decrease; Sionna Therapeutics Posts Biggest Loss

Dow Jones
·
Aug 11

Sionna Therapeutics downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
Aug 11

Sionna Therapeutics: Hold Rating Maintained as Disappointing CF Data Drive Price Target Cut from $60 to $6

TIPRANKS
·
Aug 11

Sionna Therapeutics downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Aug 11

Top Midday Decliners

MT Newswires Live
·
Aug 11

Sionna Therapeutics downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Aug 11

Citizens downgrades Sionna Therapeutics as SION-719 miss questions NBD1 thesis

TIPRANKS
·
Aug 11

U.S. Stocks on the MOVE-Microsoft, Coastal Financial

Reuters
·
Aug 11

Sionna Therapeutics falls -92.0%

TIPRANKS
·
Aug 11

Why Sionna Therapeutics Stock is Crashing 92% to a Record Low

Dow Jones
·
Aug 11

Sionna Therapeutics downgraded to Market Perform from Outperform at Citizens

TIPRANKS
·
Aug 10

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Top Midday Stories: Intel Offers $15 Billion of Common Stock; Microsoft to Ramp Up Production of Homegrown AI Chip

MT Newswires Live
·
Aug 10

Sionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond James

TIPRANKS
·
Aug 10

Sionna Therapeutics upgraded to Sector Perform from Underperform at RBC Capital

TIPRANKS
·
Aug 10

Sionna Therapeutics, Inc. : RBC Raises to Sector Perform from Underperform; Cuts Target Price to $5 from $23

THOMSON REUTERS
·
Aug 10

Tenax, Sionna Shares Sink After Trial Failures

Dow Jones
·
Aug 10

Wedbush Downgrades Sionna Therapeutics to Neutral From Outperform, Adjusts PT to $5 From $53

MT Newswires Live
·
Aug 10

Sionna Therapeutics Shares Down 91% After Co's Experimental Drug Misses Mid-Stage Trial Goal

THOMSON REUTERS
·
Aug 10

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live
·
Aug 10